WallStreetZenWallStreetZen

NASDAQ: LPTX
Leap Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Leap Therapeutics earnings were -$69.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LPTX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$15.4M, up 0% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LPTX reported annual earnings of -$67.8M, with -16.7% growth. The next LPTX earnings date is Jul 2, 2025.

LPTX earnings history

Current Revenue
$0.0
Current Earnings
-$69.4M
Current Profit Margin
0%

LPTX Return on Equity

Current Company
-162.7%
Current Industry
-60.2%
Current Market
31.5%
LPTX's Return on Equity (-162.7%)... subscribe to Premium to read more.
High Return on Equity Performance

LPTX undefined

Current Company
-120.5%
Current Industry
-2.5%
LPTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LPTX announces earnings.

LPTX undefined

Current Company
-329.07%
Current Industry
5.8%
LPTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LPTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LPTX-$68.57M-$69.40MN/A-$1.70
PMN-$933.94k-$933.94kN/A-$0.05
LEXX-$9.28M-$9.38MN/A-$0.59
HOTH-$9.62M-$9.62MN/A-$1.14
HOOK-$70.92M-$73.31MN/A-$5.84
View Top Biotech Stocks

LPTX earnings dates

Next earnings date
Jul 2, 2025

Leap Therapeutics Earnings Reports & History FAQ

What were Leap Therapeutics's earnings last quarter?

On LPTX's earnings call on Invalid Date, Leap Therapeutics (NASDAQ: LPTX) reported Q1 2025 earnings per share (EPS) of -$0.37, up 27.45% year over year. Total LPTX earnings for the quarter were -$15.44 million. In the same quarter last year, Leap Therapeutics's earnings per share (EPS) was -$0.51.

If you're new to stock investing, here's how to buy Leap Therapeutics stock.

When does Leap Therapeutics report earnings?

The next LPTX earnings call is Invalid Date. Add LPTX to your watchlist to be reminded of Leap Therapeutics's next earnings date.

Is Leap Therapeutics profitable or losing money?

As of the last Leap Therapeutics earnings report, Leap Therapeutics is currently losing money. Leap Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$69.17 million, a 29.6% increase year over year.

What was LPTX's earnings growth in the past year?

As of Leap Therapeutics's earnings date in Invalid Date, Leap Therapeutics's earnings has grown year over year. LPTX earnings in the past year totalled -$69.40 million.

What are Leap Therapeutics's earnings expectations?

The current EPS estimate for Leap Therapeutics's earnings report in Invalid Date is -$0.58.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.